Skip to main content

News

You are here

UM Ventures News

UM Ventures News
Partner News

PaxVax, Inc. Announces $105 Million Investment from Cerberus Capital Management

Wednesday, December 9, 2015

UM Baltimore Grants Pataigin, LLC, Rights to Technology Developed for Rapid, Point-of-Care Identification of Dangerous Pathogens

Tuesday, December 8, 2015

Remedy Pharmaceuticals

Remedy Pharmaceuticals Completes $9 Million Financing

Tuesday, December 1, 2015

School of Medicine Researchers Work to Develop GammaPod for Breast Cancer Therapy

Tuesday, November 24, 2015

Profectus Preclinical Data of Multi-Component Vaccine Provides Protection Against Ebola & Marburg Virus

Thursday, November 19, 2015

MedImmune

MedImmune Forms New Research Initiative with UM School of Pharmacy's Dr. Bruce Yu

Tuesday, November 3, 2015

Educational & Scientific, LLC and University of Maryland, Baltimore Sign an Agreement to Develop and Commercialize Novel Treatment for Major Cancers

Wednesday, October 28, 2015

UM Baltimore Grants Glycocept Rights to a Technology Designed to Increase the Efficacy of therapeutic Monoclonal Antibodies

Wednesday, October 28, 2015

Meenan Unveils ‘New Frontier for Innovation’

Tuesday, October 27, 2015

IMAGE: Wolfgang Losert, PhD, of UMCP, Lisa Shulman, MD, of the SOM, and Amitabh Varshney, PhD, of UMCP listen as their 2015 grant awards are announced.

2015 UMB-UMCP Seed Grants Announced

Friday, October 16, 2015

Pages